✦ LIBER ✦

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers

✍ Scribed by Robert L. Coleman; Russell R. Broaddus; Diane C. Bodurka; Judith K. Wolf; Thomas W. Burke; John J. Kavanagh; Charles F. Levenback; David M. Gershenson

Book ID: 113960293
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 110 KB
Volume: 101
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2005.09.041

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II clinical trial of bevacizumab w

Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma

✍ Tillmanns, Todd D.; Lowe, M. Patrick; Walker, Mark S.; Stepanski, Edward J.; Sch 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 322 KB

Phase II trial of imatinib mesylate in p

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube

✍ Ignacio Romero Noguera; Charlotte C. Sun; Russell R. Broaddus; Donna Branham; Ch 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 168 KB

A phase II trial of weekly docetaxel in

A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer

✍ Anna Berkenblit; Michael V. Seiden; Ursula A. Matulonis; Richard T. Penson; Caro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Imatinib mesylate in combination with do

Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis : A Hoosier Oncology Group trial

✍ Daniela Matei; Robert E. Emerson; Jeanne Schilder; Nancy Menning; Lee Ann Baldri 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 485 KB 👁 1 views

Phase II trial of pemetrexed and carbopl

Phase II trial of pemetrexed and carboplatin in platinum-sensitive recurrent ovarian, fallopian tube, and primary peritoneal cancer

✍ Van Arsdale, A.; Einstein, M.H.; Brewer, M.A.; Timmins, P.F.; Wright, J.D.; Leis 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A Phase II trial of oral capecitabine in

A Phase II trial of oral capecitabine in patients with platinum – and taxane – refractory ovarian, fallopian tube, or peritoneal cancer

✍ Judith K. Wolf; Diane C. Bodurka; Claire Verschraegen; Charlotte C. Sun; Donna B 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 167 KB